Companies › ARQT

ARCUTIS BIOTHERAPEUTICS INC (ARQT)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001787306 · EDGAR filings · Updated 2026-07-17

ARCUTIS BIOTHERAPEUTICS INC (ARQT) has reported institutional ownership of 105.7%, with 267 institutional managers holding positions valued at $3.11B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-17 — Insider transaction reported (Form 4)
• 2026-07-17 — Initial insider ownership filed (Form 3)
• 2026-07-17 — Insider transaction reported (Form 4)
• 2026-07-16 — Current report (8-K) filed
• 2026-07-15 — Notice of proposed sale filed (Form 144)
• 2026-06-17 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ARCUTIS BIOTHERAPEUTICS INC has 267 institutional holders and institutional ownership of 105.7%.

Insider activity

Insiders reported 129 transactions (9 buys, 84 sells) across 15 reporting insiders, with a net reported value of −$16.8M.

Data flags from SEC filings

Related companies

CORCEPT THERAPEUTICS INC (CORT) · TARSUS PHARMACEUTICALS INC (TARS) · IDEAYA BIOSCIENCES INC (IDYA) · ACADIA HEALTHCARE COMPANY IN (ACHC) · HIMS & HERS HEALTH INC (HIMS) · TRAVERE THERAPEUTICS INC (TVTX)